Zenith Health

{
  "main_header": {
    "sid": 841083,
    "name": "Zenith Health",
    "stock_name": "Zenith Health",
    "full_name": "Zenith Health Care Ltd",
    "name_url": "stocks-analysis/zenith-health",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "3.46",
    "chg": 0.2,
    "chgp": "6.13%",
    "dir": 1,
    "prev_price": "3.26",
    "mcapval": "19.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530665,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE812B01026",
    "curr_date": "Jul 20, 03:30 PM",
    "curr_time": "22:36 PM",
    "last_traded_at": "Jul 20, 03:30 PM IST",
    "bse_nse_vol": "1.26 lacs",
    "exc_status": "Active",
    "traded_date": "Jul 20, 2026",
    "traded_date_str": "2026 07 20",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/zenith-health-841083-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Zenith Health Care Ltd Faces Sharp Valuation Reassessment Amidst Market Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenith-health-care-ltd-faces-sharp-valuation-reassessment-amidst-market-challenges-4029371",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/ZenithHealthCar_valuationdot_4029371.png",
        "date": "2026-06-02 08:03:50",
        "description": "Zenith Health Care Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a marked deterioration in its valuation metrics, prompting a downgrade to a Strong Sell rating. The company’s price-to-earnings (P/E) ratio has surged to an astronomical level, signalling extreme overvaluation and heightened risk for investors amid weak operational performance and negative returns."
      },
      {
        "title": "Are Zenith Health Care Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-zenith-health-care-ltd-latest-results-good-or-bad-4023858",
        "imagepath": "",
        "date": "2026-05-30 19:47:55",
        "description": "Zenith Health Care Ltd's latest financial results for Q4 FY26 reveal significant operational challenges and a deterioration in performance across key metrics. The company reported a net loss of ₹0.34 crores, contrasting sharply with a profit of ₹0.11 crores in the same quarter last year. Revenue for the quarter was ₹2.62 crores, reflecting a year-on-year decline of 23.62%, although there was a sequential improvement of 5.65% from the previous quarter.\n\nThe operating margin fell to -17.56%, a substantial decline from the 0.87% margin reported a year earlier, indicating severe pricing pressures or cost management issues. Additionally, the return on equity (ROE) stood at 5.98%, which is below industry standards, highlighting inefficiencies in generating returns for shareholders.\n\nThe company's financial performance has been characterized by volatility, with quarterly revenues fluctuating significantly over the..."
      },
      {
        "title": "Zenith Health Care Ltd Gains 0.31%: Valuation Concerns and Downgrade Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenith-health-care-ltd-gains-031-valuation-concerns-and-downgrade-shape-the-week-4023093",
        "imagepath": "",
        "date": "2026-05-30 15:00:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>25 May:</strong> Stock opens at Rs.3.22, declines 0.62% amid broader Sensex rally</p>\n                    <p><strong>26 May:</strong> Stock recovers slightly to Rs.3.24 (+0.62%) despite Sensex dip</p>\n                    <p><strong>27 May:</strong> Downgrade to Strong Sell announced; stock closes at Rs.3.25 (+0.31%)</p>\n                    <p><strong>29 May:</strong> Stock holds steady at Rs.3.25; Sensex falls 1.34%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.3.24</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Clo..."
      },
      {
        "title": "Zenith Health Care Q4 FY26: Steep Losses Deepen Amid Operational Turmoil",
        "link": "https://www.marketsmojo.com/news/result-analysis/zenith-health-care-q4-fy26-steep-losses-deepen-amid-operational-turmoil-4023081",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZenithHealthCar_quaterlyResult_4023081.png",
        "date": "2026-05-29 23:49:55",
        "description": "Zenith Healthcare Limited has reported deeply concerning results for Q4 FY26 (January-March 2026), posting a net loss of ₹0.34 crores compared to a profit of ₹0.11 crores in the year-ago quarter, marking a complete reversal in profitability. The micro-cap pharmaceutical manufacturer, with a market capitalisation of just ₹17.00 crores, saw revenues decline 23.62% year-on-year to ₹2.62 crores whilst operating margins collapsed into negative territory at -17.56%, raising serious questions about operational viability."
      },
      {
        "title": "Zenith Health Care Ltd Downgraded to Strong Sell Amid Valuation Concerns and Weak Fundamentals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenith-health-care-ltd-downgraded-to-strong-sell-amid-valuation-concerns-and-weak-fundamentals-4015948",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZenithHealthCar_mojoScore_4015948.png",
        "date": "2026-05-27 08:19:27",
        "description": "Zenith Health Care Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 26 May 2026. This revision reflects a comprehensive reassessment of the company’s valuation, financial trends, quality metrics, and technical outlook, signalling heightened caution for investors amid expensive valuations and persistent fundamental weaknesses."
      },
      {
        "title": "Zenith Health Care Ltd Valuation Shifts Signal Price Attractiveness Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenith-health-care-ltd-valuation-shifts-signal-price-attractiveness-challenges-4015608",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZenithHealthCar_valuationdot_4015608.png",
        "date": "2026-05-27 08:01:15",
        "description": "Zenith Health Care Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift notably, raising questions about its price attractiveness amid a challenging market backdrop. The company’s price-to-earnings (P/E) ratio has climbed to 38.93, moving from a previously fair valuation to an expensive territory, while its price-to-book value (P/BV) stands at 2.33. This article analyses these valuation changes in the context of historical trends, peer comparisons, and broader market performance to provide a comprehensive view for investors."
      },
      {
        "title": "Zenith Health Care Ltd Gains 6.23%: Valuation Shift and Technical Upgrade Drive Weekly Move",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/zenith-health-care-ltd-gains-623-valuation-shift-and-technical-upgrade-drive-weekly-move-4008440",
        "imagepath": "",
        "date": "2026-05-23 15:03:18",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>18 May:</strong> Valuation shifts signal changing market sentiment</p>\n                    <p><strong>19 May:</strong> Mojo grade upgraded from Strong Sell to Sell</p>\n                    <p><strong>20 May:</strong> Stock price rises 1.89% on improved technicals</p>\n                    <p><strong>22 May:</strong> Week closes at Rs.3.24, up 6.23% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.3.05</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.3.24</div><div class=\"st..."
      },
      {
        "title": "When is the next results date for Zenith Health Care Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-zenith-health-care-ltd-4001709",
        "imagepath": "",
        "date": "2026-05-20 23:18:38",
        "description": "The next results date for Zenith Health Care Ltd is scheduled for 29 May 2026...."
      },
      {
        "title": "Zenith Health Care Ltd Upgraded to Sell on Improved Technicals and Valuation",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/zenith-health-care-ltd-upgraded-to-sell-on-improved-technicals-and-valuation-4000349",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ZenithHealthCar_mojoScore_4000349.png",
        "date": "2026-05-20 08:15:58",
        "description": "Zenith Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced improvement in its technical outlook and valuation metrics despite ongoing fundamental challenges. The Pharmaceuticals & Biotechnology micro-cap’s recent performance and financial data have prompted a reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals."
      }
    ],
    "total": 118,
    "sid": "841083",
    "stock_news_url": "https://www.marketsmojo.com/news/zenith-health-care-841083"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Scheme of Arrangement",
      "datetime": "14-Jul-2026",
      "details": "After considering the recommendation of the Audit Committee and the Committee of Independent Directors of the Company has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme) under Sections 230 to 232 and other applicable provisions of the Companies Act 2013 (Act) rules and regulations made thereunder read with Section 2 (6) of the Income Tax Act 2025 for the aforementioned amalgamation consequent dissolution of the Transferor Company without winding up and the issuance of equity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration.",
      "source": "BSE"
    },
    {
      "caption": "Corporate Action-Amalgamation/ Merger / Demerger",
      "datetime": "14-Jul-2026",
      "details": "After considering the recommendation of the Audit Committe and the Committe of Independent Directors of the Company has inter-alia considered and approved a Scheme of Amalgamation of Achyut Healthcare Limited (Transferor Company) with and into Zenith Healthcare Limited (Transferee Company) and their respective shareholders and creditors (Scheme) under Section 230 to 232 and other applicable provisions of the Companies Act 2013 (Act) rules and regulations made thereunder read with Section 2(6) of the Income Tax Act 2025 for the aforementioned amalgamation consequent dissolution of the Transferor Company without winding up and the issuance of quity shares by the Transferee Company to the equity shareholders of the Transferor Company as consideration.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Held On Tuesday July 14 2026 And The Disclosure Pursuant To Regulation 30 Of The SEBI (LODR) Regulations 2015 Regarding The Approval Of The Scheme Of Amalgamation Of Achyut Healthcare Limited With And Into Zenith He",
      "datetime": "14-Jul-2026",
      "details": "Outcome of the Board Meeting held on Tuesday July 14 2026 and the disclosure pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 regarding the approval of the Scheme of Amalgamation of Achyut Healthcare Limited with and into Zenith Healthcare Limited.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Zenith Health Care Ltd Faces Sharp Valuation Reassessment Amidst Market Challenges

2026-06-02 08:03:50

Zenith Health Care Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a marked deterioration in its valuation metrics, prompting a downgrade to a Strong Sell rating. The company’s price-to-earnings (P/E) ratio has surged to an astronomical level, signalling extreme overvaluation and heightened risk for investors amid weak operational performance and negative returns.

Read full news article

Are Zenith Health Care Ltd latest results good or bad?

2026-05-30 19:47:55

Zenith Health Care Ltd's latest financial results for Q4 FY26 reveal significant operational challenges and a deterioration in performance across key metrics. The company reported a net loss of ₹0.34 crores, contrasting sharply with a profit of ₹0.11 crores in the same quarter last year. Revenue for the quarter was ₹2.62 crores, reflecting a year-on-year decline of 23.62%, although there was a sequential improvement of 5.65% from the previous quarter. The operating margin fell to -17.56%, a substantial decline from the 0.87% margin reported a year earlier, indicating severe pricing pressures or cost management issues. Additionally, the return on equity (ROE) stood at 5.98%, which is below industry standards, highlighting inefficiencies in generating returns for shareholders. The company's financial performance has been characterized by volatility, with quarterly revenues fluctuating significantly over the...

Read full news article

Zenith Health Care Ltd Gains 0.31%: Valuation Concerns and Downgrade Shape the Week

2026-05-30 15:00:05

Key Events This Week

25 May: Stock opens at Rs.3.22, declines 0.62% amid broader Sensex rally

26 May: Stock recovers slightly to Rs.3.24 (+0.62%) despite Sensex dip

27 May: Downgrade to Strong Sell announced; stock closes at Rs.3.25 (+0.31%)

29 May: Stock holds steady at Rs.3.25; Sensex falls 1.34%

Week Open

Rs.3.24

Week Clo...

Read full news article

Zenith Health Care Q4 FY26: Steep Losses Deepen Amid Operational Turmoil

2026-05-29 23:49:55

Zenith Healthcare Limited has reported deeply concerning results for Q4 FY26 (January-March 2026), posting a net loss of ₹0.34 crores compared to a profit of ₹0.11 crores in the year-ago quarter, marking a complete reversal in profitability. The micro-cap pharmaceutical manufacturer, with a market capitalisation of just ₹17.00 crores, saw revenues decline 23.62% year-on-year to ₹2.62 crores whilst operating margins collapsed into negative territory at -17.56%, raising serious questions about operational viability.

Read full news article

Zenith Health Care Ltd Downgraded to Strong Sell Amid Valuation Concerns and Weak Fundamentals

2026-05-27 08:19:27

Zenith Health Care Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has been downgraded from a Sell to a Strong Sell rating as of 26 May 2026. This revision reflects a comprehensive reassessment of the company’s valuation, financial trends, quality metrics, and technical outlook, signalling heightened caution for investors amid expensive valuations and persistent fundamental weaknesses.

Read full news article

Zenith Health Care Ltd Valuation Shifts Signal Price Attractiveness Challenges

2026-05-27 08:01:15

Zenith Health Care Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift notably, raising questions about its price attractiveness amid a challenging market backdrop. The company’s price-to-earnings (P/E) ratio has climbed to 38.93, moving from a previously fair valuation to an expensive territory, while its price-to-book value (P/BV) stands at 2.33. This article analyses these valuation changes in the context of historical trends, peer comparisons, and broader market performance to provide a comprehensive view for investors.

Read full news article

Zenith Health Care Ltd Gains 6.23%: Valuation Shift and Technical Upgrade Drive Weekly Move

2026-05-23 15:03:18

Key Events This Week

18 May: Valuation shifts signal changing market sentiment

19 May: Mojo grade upgraded from Strong Sell to Sell

20 May: Stock price rises 1.89% on improved technicals

22 May: Week closes at Rs.3.24, up 6.23% for the week

Week Open

Rs.3.05

Week Close

Rs.3.24

Read full news article

When is the next results date for Zenith Health Care Ltd?

2026-05-20 23:18:38

The next results date for Zenith Health Care Ltd is scheduled for 29 May 2026....

Read full news article

Zenith Health Care Ltd Upgraded to Sell on Improved Technicals and Valuation

2026-05-20 08:15:58

Zenith Health Care Ltd has seen its investment rating upgraded from Strong Sell to Sell, reflecting a nuanced improvement in its technical outlook and valuation metrics despite ongoing fundamental challenges. The Pharmaceuticals & Biotechnology micro-cap’s recent performance and financial data have prompted a reassessment across four key parameters: Quality, Valuation, Financial Trend, and Technicals.

Read full news article

View All News